Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00588913
First received: December 20, 2007
Last updated: July 9, 2013
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)